|
Clinical study of CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid MalignanciesEntering the 21st century ,several tumor immunotherapy success in clinical trial make the immunotherapy very hot in research field. Especially after 2010, CAR-T cell immunotherapy have an amazing effect on B cell Malignant Tumors. What is CAR-T cell immunotherapy? T cells are collected from a patient,they are genetically engineered to produce chimeric antigen receptors (CARs) on their surface.After this reengineering, the T cells are known as “chimeric antigen receptor (CAR) T cells.” CARs are proteins that allow the T cells to recognize an antigen on targeted tumor cells.The CAR T cells are then infused into the patient and they are the “attacker” cells that will recognize, and kill, cancerous cells that have the targeted antigen on their surface. Hebei Senlang Biotechnology Co., Ltd together Second Hospital of Hebei Medical University develop the CAR-T cell immunotherapy clinical study ,use the CD19 as target for CD19+ Patients With Relapsed or Refractory Blood Malignant Tumors ( main including ALL and B-cell Lymphoma) | ![]() Second Hospital of Hebei Medical University hematology department Director Luo jianmin 0311-66002304
Hebei Senlang Biotechnology Co., Ltd Ph.D. Li jianqiang 15511369555 |
ABOUT US
----------Senlang CAR-T----------
![]() 先进技术来源 森朗CAR-T技术来源于CAR-T技术 三大发源地之一,美国西雅图 Fred Hutchinson癌......更多 | ![]() 资深研发专家 高级科学家李建强博士一直致力于 肿瘤免疫治疗的基础研究、临床研 发以及产品的临床转化......更多 | ![]() 权威临床队伍 以河北医科大学第二医院血液科罗 建民主任领衔的临床团队,在血液 病的诊断与治疗方面有着......更多 | ![]() 保险保?#20808;?#30410; 项目组为每名参与研究的患者购买临 床试验责任保险,患者在限定区域范 围内参与该项研究,发生超......更多 | ![]() 捐赠技术服务 本研究中CAR-T细胞生产及治疗 的相关费用由申办方承担,对您 免费。免费范围包括T......更多 |
| Room 512 and 513, Building 1, 136 Huanghe Avenue, Shijiazhuang High-tech Development Zone, Hebei Province,China Tel:+86-311-82970975、82970973 |